Myelodysplastic syndrome as a complication of neo-adjuvant triple M chemotherapy and radiotherapy

Clinical Oncology

Volumn 11, Issue 3, 1999, Pages 187-189

  Partridge, S E ^a   Lowdell, C P ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Methotrexate; Mitomycin C; Mitoxantrone; Myelodysplastic syndrome; Radiotherapy

Indexed keywords

ALKYLATING AGENT; GROWTH FACTOR; INTERFERON; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; RETINOID; STEROID; VITAMIN D DERIVATIVE;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; BREAST CANCER; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; FEMALE; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0032806169     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.1999.9039     Document Type: Article

References (9)

1. Hagop M, Kantarjan HM, Estey EH, et al. Treatment of therapy related leukemia and the myelodysplastic syndrome. Hematol Oncol Clin North Am 1993;7:81-107.
2. Giles FJ, Koeffler HP. Secondary myelodysplastic syndromes and leukaemias. Curr Opin Haematol 1994;1:256-60.
3. Pedersen-Bjergaard J, Philip P. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myeldysplasia and leukaemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood 1991;78:1147-8.
4. Van Leeuwen FE. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment. Baillieres Clin Haematol 1996;9:57:85.
5. Tallman MS, Gray R, Bennett JM, et al. Leukaemogenic potential of adjuvant chemotherapy for early stage breast cancer; the Eastern Cooperative Oncology Group experience. J Clin Oncol 1995;13:1557-63.
6. Pedersen-Bjergaard J, Philip P, Larsen SO, et al. Therapyrelated myelodysplasia and acute myeloid leukaemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993;12:1975-86.
7. Curtis RE, Boice JD, Stovall MPH, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-51.
8. Buchbinder R, Hall S, Larson SO, et al. Severe bone marrow failure due to low dose oral methotrexate. J Rheumatol 1988;15:1586-7.
9. Ratain MJ, Rowley JD. Therapy-related acute myeloid leukaemia secondary to inhibitors of topoisomerase II: from the bed-side to the target genes. Ann Oncol 1992;2:107-11.